M K Proteins Ltd
NSE:MKPL
M K Proteins Ltd
NSE:MKPL
Price:
5.18
INR
-0.58%
Market Closed
Market Cap:
₹1.9B
Balance Sheet
Balance Sheet Decomposition
M K Proteins Ltd
M K Proteins Ltd
Balance Sheet Decomposition is not available for
M K Proteins Ltd
M K Proteins Ltd
Balance Sheet
M K Proteins Ltd
M K Proteins Ltd
Currency: INR
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
4
|
1
|
0
|
4
|
0
|
0
|
1
|
1
|
0
|
|
| Cash Equivalents |
4
|
1
|
0
|
4
|
0
|
0
|
1
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
81
|
64
|
68
|
111
|
56
|
325
|
305
|
36
|
66
|
|
| Accounts Receivables |
74
|
62
|
54
|
107
|
46
|
292
|
164
|
36
|
14
|
|
| Other Receivables |
7
|
2
|
14
|
5
|
10
|
33
|
141
|
0
|
52
|
|
| Inventory |
87
|
189
|
218
|
201
|
333
|
498
|
712
|
793
|
1 113
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
6
|
|
| Total Current Assets |
172
|
254
|
286
|
317
|
389
|
823
|
1 018
|
858
|
1 185
|
|
| PP&E Net |
37
|
65
|
63
|
72
|
70
|
31
|
24
|
87
|
103
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
103
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
99
|
|
| Note Receivable |
3
|
2
|
2
|
3
|
4
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
7
|
8
|
13
|
17
|
|
| Total Assets |
213
N/A
|
320
+51%
|
351
+9%
|
391
+11%
|
466
+19%
|
861
+85%
|
1 049
+22%
|
962
-8%
|
1 306
+36%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
14
|
18
|
121
|
77
|
94
|
50
|
48
|
115
|
193
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
131
|
177
|
123
|
179
|
181
|
340
|
419
|
0
|
365
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
191
|
4
|
|
| Other Current Liabilities |
5
|
6
|
6
|
20
|
25
|
47
|
52
|
34
|
27
|
|
| Total Current Liabilities |
150
|
201
|
250
|
275
|
300
|
438
|
520
|
340
|
590
|
|
| Long-Term Debt |
50
|
101
|
73
|
80
|
121
|
27
|
25
|
10
|
18
|
|
| Deferred Income Tax |
1
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
| Total Liabilities |
201
N/A
|
303
+51%
|
325
+7%
|
358
+10%
|
423
+18%
|
465
+10%
|
547
+17%
|
352
-36%
|
611
+74%
|
|
| Equity | ||||||||||
| Common Stock |
7
|
7
|
7
|
7
|
27
|
42
|
125
|
375
|
375
|
|
| Retained Earnings |
5
|
10
|
19
|
26
|
16
|
354
|
378
|
235
|
0
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
320
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
12
N/A
|
17
+40%
|
25
+49%
|
33
+29%
|
43
+30%
|
396
+830%
|
503
+27%
|
611
+21%
|
695
+14%
|
|
| Total Liabilities & Equity |
213
N/A
|
320
+51%
|
351
+9%
|
391
+11%
|
466
+19%
|
861
+85%
|
1 049
+22%
|
962
-8%
|
1 306
+36%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
13
|
8
|
375
|
375
|
375
|
375
|
|
Switch to:
Switch to:
See Also
Discover More
